What is geletide and who founded the company?
Executive summary
No reliable sources in the provided reporting identify a company called “Geletide”; available documents instead discuss similarly named firms—Gelest (a specialty chemicals company) and Gelesis (a biotechnology company)—which are frequently conflated in informal discourse, so the most responsible answer is to outline what is known about those two entities and to report that “Geletide” does not appear in the supplied sources [1] [2] [3].
1. The likely confusion: “Geletide” vs. Gelest and Gelesis
Search results supplied return multiple companies with similar names (Gelest, Gelesis, Gelita, Gelid, Geidea, Geltor) but none explicitly named “Geletide,” indicating either a misspelling, a non-public startup, or a name not covered by the provided reporting; the record therefore requires caution before asserting the existence or founders of “Geletide” [1] [2] [4] [5].
2. If the intended target is Gelest: what Gelest does
Gelest, Inc. is a manufacturer and supplier of silicones, organosilanes, metal-organic compounds and specialty monomers that serve advanced-technology markets including medical devices, life sciences, microelectronics and personal care, and it operates as a Mitsubishi Chemical subsidiary with headquarters in Morrisville, Pennsylvania [1].
3. If the intended target is Gelest: who founded Gelest
Gelest was founded in 1991 by Dr. Barry Arkles, Ph.D.; Arkles is repeatedly identified in corporate and trade reporting as Gelest’s founder, a longtime leader who has served as CEO and chairman and who resumed executive leadership at moments of transition [1] [6] [7] [8].
4. If the intended target is Gelesis: what Gelesis does
Gelesis is a Boston-area biotechnology company that developed Plenity® (also called Gelesis100), a superabsorbent hydrogel–based, FDA-cleared device/therapeutic intended to aid weight management by expanding in the stomach to promote satiety; Gelesis focuses on treatments for overweight and obesity and has been the subject of public filings and business-combination press releases [2] [9].
5. If the intended target is Gelesis: who founded Gelesis
Gelesis traces to an initiative founded by PureTech Ventures (a life‑sciences venture firm) together with Israeli R&D partners; company records and profiles list founders and early leaders including PureTech affiliates and entrepreneurs such as Yishai Zohar and Eyal S. Ron, with Zohar cited as a company founder and CEO in press material and databases [2] [3] [9] [10].
6. Why naming matters: corporate framing and source types
The supplied materials are a mix of company press releases, corporate web pages and third‑party profiles; these sources reliably convey how firms present themselves and their founders (for example Gelest’s site and press about Arkles, and PureTech/Gelesis releases about Plenity), but they also reflect corporate framing and promotional aims—meaning independent verification from regulatory filings or neutral reporting would be ideal for contested details [1] [3] [9].
7. Conclusion and reporting limitation
Based solely on the provided reporting, there is no evidence in these sources for a firm named “Geletide”; if the query intends Gelest, the company is a specialty-silicon/organometallic chemicals maker founded by Barry Arkles in 1991 [1] [8], whereas if the query intends Gelesis, that biotech was founded as a PureTech‑backed entity with founders and executives such as Yishai Zohar and Eyal S. Ron involved in its creation and commercialization of Plenity [2] [9] [10]. If “Geletide” is a distinct entity, it is not documented in the supplied sources and further corroboration from a business registry, corporate website or press coverage would be required to identify its business and founder [1] [2].